Singh Nina, Wannstedt Cheryl, Keyes Lois, Wagener Marilyn M, de Vera Michael, Cacciarelli Thomas V, Gayowski Timothy
Veterans Affairs Medical Center, Pittsburgh, Pennsylvania 15240, USA. nis5+@pitt.edu
Transplantation. 2004 Jan 15;77(1):106-10. doi: 10.1097/01.TP.0000101289.80832.37.
This study determines whether the recipient and donor characteristics that influence the cytomegalovirus (CMV) infection rate after liver transplantation have changed.
The recipient and donor characteristics that may affect the rate of CMV infection were assessed in 232 liver transplant recipients at our institution during a 14-year period (1989-2003).
Since 1989, the age of recipients (P=0.0001) and donors (P=0.0001) has increased significantly. Pretransplant CMV seropositivity in recipients has decreased significantly (P=0.0001, 86.4% [1989-1992] to 53.7% [2000-2003]), whereas donor CMV seropositivity has remained unchanged (P>0.20). As a result, there has been a significant increase in the proportion of high-risk (CMV recipient-/donor+) patients (P=0.012); 10.6% of recipients from 1989 to 1992 versus 24.1% of recipients from 2000 to 2003 were CMV recipient-/donor+. The Child-Pugh scores of recipients have remained unchanged over time. However, the proportion of patients undergoing transplantation while being cared for in the intensive care unit has decreased significantly over time (P=0.0002). Despite an increase in the rate of CMV infection (P=0.09), the incidence of CMV disease has decreased significantly (P=0.0004).
The proportion of high-risk patients (CMV recipient-/donor+) has increased significantly over time, attributable largely to a declining rate of CMV seropositivity in recipients before transplantation. These data have implications for guiding prophylactic practices and resource use after liver transplantation.
本研究旨在确定影响肝移植后巨细胞病毒(CMV)感染率的受者和供者特征是否发生了变化。
在14年期间(1989 - 2003年),对我院232例肝移植受者可能影响CMV感染率的受者和供者特征进行了评估。
自1989年以来,受者(P = 0.0001)和供者(P = 0.0001)的年龄显著增加。受者移植前CMV血清学阳性率显著下降(P = 0.0001,从1989 - 1992年的86.4%降至2000 - 2003年的53.7%),而供者CMV血清学阳性率保持不变(P>0.20)。因此,高危(CMV受者阴性/供者阳性)患者的比例显著增加(P = 0.012);1989 - 1992年的受者中有10.6%为CMV受者阴性/供者阳性,而2000 - 2003年的受者中有24.1%为CMV受者阴性/供者阳性。受者的Child-Pugh评分随时间保持不变。然而,在重症监护病房接受治疗期间接受移植的患者比例随时间显著下降(P = 0.0002)。尽管CMV感染率有所增加(P = 0.09),但CMV疾病的发病率显著下降(P = 0.0004)。
随着时间的推移,高危患者(CMV受者阴性/供者阳性)的比例显著增加,这主要归因于移植前受者中CMV血清学阳性率的下降。这些数据对指导肝移植后的预防措施和资源利用具有重要意义。